600721.SS SHH
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
1W: -9.4%
1M: -5.7%
3M: +90.0%
YTD: +40.5%
1Y: +62.2%
3Y: +80.6%
5Y: +190.0%
¥13.11 ($1.95)
+0.16 (+1.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$388M
+0.5% ▲
5Y CAGR: +35.6%
Gross Profit
$167M
+3.4% ▲
Operating Income
$50M
+35.1% ▲
Net Income
$41M
-1.9% ▼
EPS (Diluted)
$0.11
+0.0% ▲
EBITDA
$50M
-8.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $281M | $350M | $369M | $386M | $388M |
| YoY Growth | +232.8% | +24.4% | +5.5% | +4.5% | +0.5% |
| Cost of Revenue | $169M | $210M | $188M | $188M | $220M |
| Gross Profit | $113M | $94M | $181M | $197M | $167M |
| Gross Margin | 40.0% | 27.0% | 49.0% | 51.2% | 43.1% |
| R&D Expenses | $5M | $27M | $32M | $30M | $0 |
| SG&A Expenses | $25M | $33M | $52M | $52M | $68M |
| Operating Expenses | $49M | $170M | $163M | $160M | $117M |
| Operating Income | $64M | -$31M | $18M | $37M | $50M |
| Operating Margin | 22.6% | -8.8% | 4.9% | 9.6% | 12.9% |
| Interest Expense | $47K | $113K | $63K | $60K | $81K |
| Income Before Tax | $62M | -$32M | $16M | $37M | $44M |
| Tax Expense | $2M | $3M | $4M | -$5M | $3M |
| Net Income | $60M | -$35M | $13M | $41M | $41M |
| Net Margin | 21.3% | -9.9% | 3.5% | 10.8% | 10.5% |
| EPS (Diluted) | $0.16 | $-0.09 | $0.03 | $0.11 | $0.11 |
| EBITDA | $87M | -$2M | $40M | $55M | $50M |
| Shares Outstanding | 375M | 376M | 379M | 383M | 384M |